Fennec Pharmaceuticals Inc (FRX.TO)
9.275
-0.16
(-1.75%)
CAD |
TSX |
Jun 14, 16:00
Fennec Pharmaceuticals Gross Profit Margin (Quarterly): 97.83% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 97.83% |
December 31, 2023 | 92.96% |
September 30, 2023 | 94.92% |
Date | Value |
---|---|
June 30, 2023 | 95.55% |
March 31, 2023 | 94.34% |
December 31, 2022 | 94.40% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
92.96%
Minimum
Dec 2023
97.83%
Maximum
Mar 2024
95.00%
Average
94.66%
Median
Gross Profit Margin (Quarterly) Benchmarks
Ionic Brands Corp | -- |
4Front Ventures Corp | 40.20% |
Green Thumb Industries Inc | 52.55% |
Lowell Farms Inc | -16.97% |
Bright Minds Biosciences Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | 9.10% |
Return on Invested Capital | 13.93% |
Profit Margin (Quarterly) | 50.59% |
Operating Margin (Quarterly) | 54.08% |